Request for Covid-19 Impact Assessment of this Report

Healthcare

Global G-CSF Biosimilars Market Analysis 2015-2019 and Forecast 2020-2025

  • 99S3485495
  • 97 Pages
  • January 2020
  • Healthcare
Download Sample    Get Discount   
 
Snapshot

The global G-CSF Biosimilars market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of G-CSF Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Human Growth Hormone

Erythropoietin

Monoclonal Antibodies

Insulin

Interferon

Granulocyte-Colony Stimulating Factor

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Pfizer

Novartis

Roche

Merck & Co.

Sanofi

Johnson & Johnson

Gilead Science

GlaxoSmithKline

AbbVie

Amgen

AstraZeneca

Bayer

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Blood Disorders

Oncology Diseases

Chronic And Autoimmune Diseases

Growth Hormone Deficiencies

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Content

1 Industry Overview

1.1 G-CSF Biosimilars Industry

Figure G-CSF Biosimilars Industry Chain Structure

1.1.1 Overview

1.1.2 Development of G-CSF Biosimilars

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of G-CSF Biosimilars

1.2.2 Downstream

Table Application Segment of G-CSF Biosimilars

Table Global G-CSF Biosimilars Market 2015-2025, by Application, in USD Million

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 G-CSF Biosimilars Market by Type

3.1 By Type

3.1.1 Human Growth Hormone

Table Major Company List of Human Growth Hormone

3.1.2 Erythropoietin

Table Major Company List of Erythropoietin

3.1.3 Monoclonal Antibodies

Table Major Company List of Monoclonal Antibodies

3.1.4 Insulin

Table Major Company List of Insulin

3.1.5 Interferon

Table Major Company List of Interferon

3.1.6 Granulocyte-Colony Stimulating Factor

Table Major Company List of Granulocyte-Colony Stimulating Factor

3.2 Market Size

Table Global G-CSF Biosimilars Market 2015-2019, by Type, in USD Million

Figure Global G-CSF Biosimilars Market Growth 2015-2019, by Type, in USD Million

Table Global G-CSF Biosimilars Market 2015-2019, by Type, in Volume

Figure Global G-CSF Biosimilars Market Growth 2015-2019, by Type, in Volume

3.3 Market Forecast

Table Global G-CSF Biosimilars Market Forecast 2020-2025, by Type, in USD Million

Table Global G-CSF Biosimilars Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

4.1 Pfizer (Company Profile, Sales Data etc.)

4.1.1 Pfizer Profile

Table Pfizer Overview List

4.1.2 Pfizer Products & Services

4.1.3 Pfizer Business Operation Conditions

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 Novartis (Company Profile, Sales Data etc.)

4.2.1 Novartis Profile

Table Novartis Overview List

4.2.2 Novartis Products & Services

4.2.3 Novartis Business Operation Conditions

Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Roche (Company Profile, Sales Data etc.)

4.3.1 Roche Profile

Table Roche Overview List

4.3.2 Roche Products & Services

4.3.3 Roche Business Operation Conditions

Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Merck & Co. (Company Profile, Sales Data etc.)

4.4.1 Merck & Co. Profile

Table Merck & Co. Overview List

4.4.2 Merck & Co. Products & Services

4.4.3 Merck & Co. Business Operation Conditions

Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Sanofi (Company Profile, Sales Data etc.)

4.5.1 Sanofi Profile

Table Sanofi Overview List

4.5.2 Sanofi Products & Services

4.5.3 Sanofi Business Operation Conditions

Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 Johnson & Johnson (Company Profile, Sales Data etc.)

4.6.1 Johnson & Johnson Profile

Table Johnson & Johnson Overview List

4.6.2 Johnson & Johnson Products & Services

4.6.3 Johnson & Johnson Business Operation Conditions

Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Gilead Science (Company Profile, Sales Data etc.)

4.7.1 Gilead Science Profile

Table Gilead Science Overview List

4.7.2 Gilead Science Products & Services

4.7.3 Gilead Science Business Operation Conditions

Table Business Operation of Gilead Science (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 GlaxoSmithKline (Company Profile, Sales Data etc.)

4.8.1 GlaxoSmithKline Profile

Table GlaxoSmithKline Overview List

4.8.2 GlaxoSmithKline Products & Services

4.8.3 GlaxoSmithKline Business Operation Conditions

Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.9 AbbVie (Company Profile, Sales Data etc.)

4.9.1 AbbVie Profile

Table AbbVie Overview List

4.9.2 AbbVie Products & Services

4.9.3 AbbVie Business Operation Conditions

Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.10 Amgen (Company Profile, Sales Data etc.)

4.10.1 Amgen Profile

Table Amgen Overview List

4.10.2 Amgen Products & Services

4.10.3 Amgen Business Operation Conditions

Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.11 AstraZeneca (Company Profile, Sales Data etc.)

4.11.1 AstraZeneca Profile

Table AstraZeneca Overview List

4.11.2 AstraZeneca Products & Services

4.11.3 AstraZeneca Business Operation Conditions

Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.12 Bayer (Company Profile, Sales Data etc.)

4.12.1 Bayer Profile

Table Bayer Overview List

4.12.2 Bayer Products & Services

4.12.3 Bayer Business Operation Conditions

Table Business Operation of Bayer (Sales Revenue, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global G-CSF Biosimilars Sales Revenue 2015-2019, by Company, in USD Million

Table Global G-CSF Biosimilars Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global G-CSF Biosimilars Sales Revenue Share in 2019, by Company, in USD Million

Table Global G-CSF Biosimilars Sales Volume 2015-2019, by Company, in Volume

Table Global G-CSF Biosimilars Sales Volume Share 2015-2019, by Company, in Volume

Figure Global G-CSF Biosimilars Sales Volume Share in 2019, by Company, in Volume

5.2 Regional Market by Company

Figure North America G-CSF Biosimilars Market Concentration, in 2019

Figure Europe G-CSF Biosimilars Market Market Concentration, in 2019

Figure Asia-Pacific G-CSF Biosimilars MMarket Concentration, in 2019

Figure South America G-CSF Biosimilars Market Concentration, in 2019

Figure Middle East & Africa G-CSF Biosimilars Market Concentration, in 2019

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Blood Disorders

Figure G-CSF Biosimilars Demand in Blood Disorders, 2015-2019, in USD Million

Figure G-CSF Biosimilars Demand in Blood Disorders, 2015-2019, in Volume

6.1.2 Demand in Oncology Diseases

Figure G-CSF Biosimilars Demand in Oncology Diseases, 2015-2019, in USD Million

Figure G-CSF Biosimilars Demand in Oncology Diseases, 2015-2019, in Volume

6.1.3 Demand in Chronic And Autoimmune Diseases

Figure G-CSF Biosimilars Demand in Chronic And Autoimmune Diseases, 2015-2019, in USD Million

Figure G-CSF Biosimilars Demand in Chronic And Autoimmune Diseases, 2015-2019, in Volume

6.1.4 Demand in Growth Hormone Deficiencies

Figure G-CSF Biosimilars Demand in Growth Hormone Deficiencies, 2015-2019, in USD Million

Figure G-CSF Biosimilars Demand in Growth Hormone Deficiencies, 2015-2019, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table G-CSF Biosimilars Demand Forecast 2020-2025, by Application, in USD Million

Figure G-CSF Biosimilars Market Growth 2020-2025, by Application, in USD Million

Figure G-CSF Biosimilars Market Share in 2025, by Application, in USD Million

Table G-CSF Biosimilars Demand Forecast 2020-2025, by Application, in Volume

Table G-CSF Biosimilars Market Growth 2020-2025, by Application, in Volume

Table G-CSF Biosimilars Market Share in 2025, by Application, in Volume

7 Region Operation

7.1 Regional Production

Table G-CSF Biosimilars Production 2015-2019, by Region, in USD Million

Table G-CSF Biosimilars Production 2015-2019, by Region, in Volume

7.2 Regional Market

Table Global G-CSF Biosimilars Market 2015-2019, by Region, in USD Million

Table Global G-CSF Biosimilars Market Share 2015-2019, by Region, in USD Million

Table Global G-CSF Biosimilars Market 2015-2019, by Region, in Volume

Table Global G-CSF Biosimilars Market Share 2015-2019, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America G-CSF Biosimilars Market Size and Growth 2015-2019, in USD Million

Figure North America G-CSF Biosimilars Market Size and Growth 2015-2019, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table North America G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe G-CSF Biosimilars Market Size and Growth 2015-2019, in USD Million

Figure Europe G-CSF Biosimilars Market Size and Growth 2015-2019, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table Europe G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific G-CSF Biosimilars Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific G-CSF Biosimilars Market Size and Growth 2015-2019, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America G-CSF Biosimilars Market Size and Growth 2015-2019, in USD Million

Figure South America G-CSF Biosimilars Market Size and Growth 2015-2019, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table South America G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa G-CSF Biosimilars Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa G-CSF Biosimilars Market Size and Growth 2015-2019, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table G-CSF Biosimilars Market Forecast 2020-2025, by Region, in USD Million

Table G-CSF Biosimilars Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

List of Table

List of Table

Table Upstream Segment of G-CSF Biosimilars

Table Application Segment of G-CSF Biosimilars

Table Global G-CSF Biosimilars Market 2015-2025, by Application, in USD Million

Table Major Company List of Erythropoietin

Table Major Company List of Monoclonal Antibodies

Table Major Company List of Insulin

Table Major Company List of Interferon

Table Major Company List of Granulocyte-Colony Stimulating Factor

Table Global G-CSF Biosimilars Market 2015-2019, by Type, in USD Million

Table Global G-CSF Biosimilars Market 2015-2019, by Type, in Volume

Table Global G-CSF Biosimilars Market Forecast 2020-2025, by Type, in USD Million

Table Global G-CSF Biosimilars Market Forecast 2020-2025, by Type, in Volume

Table Pfizer Overview List

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck & Co. Overview List

Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gilead Science Overview List

Table Business Operation of Gilead Science (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AbbVie Overview List

Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer Overview List

Table Business Operation of Bayer (Sales Revenue, Cost, Gross Margin)

Table Global G-CSF Biosimilars Sales Revenue 2015-2019, by Company, in USD Million

Table Global G-CSF Biosimilars Sales Revenue Share 2015-2019, by Company, in USD Million

Table Global G-CSF Biosimilars Sales Volume 2015-2019, by Company, in Volume

Table Global G-CSF Biosimilars Sales Volume Share 2015-2019, by Company, in Volume

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table G-CSF Biosimilars Demand Forecast 2020-2025, by Application, in USD Million

Table G-CSF Biosimilars Demand Forecast 2020-2025, by Application, in Volume

Table G-CSF Biosimilars Market Growth 2020-2025, by Application, in Volume

Table G-CSF Biosimilars Market Share in 2025, by Application, in Volume

Table G-CSF Biosimilars Production 2015-2019, by Region, in USD Million

Table G-CSF Biosimilars Production 2015-2019, by Region, in Volume

Table Global G-CSF Biosimilars Market 2015-2019, by Region, in USD Million

Table Global G-CSF Biosimilars Market Share 2015-2019, by Region, in USD Million

Table Global G-CSF Biosimilars Market 2015-2019, by Region, in Volume

Table Global G-CSF Biosimilars Market Share 2015-2019, by Region, in Volume

Table North America G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table North America G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

Table Europe G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table Europe G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

Table Asia-Pacific G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

Table South America G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table South America G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

Table Middle East & Africa G-CSF Biosimilars Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa G-CSF Biosimilars Market Size 2015-2019, by Country, in Volume

Table G-CSF Biosimilars Market Forecast 2020-2025, by Region, in USD Million

Table G-CSF Biosimilars Market Forecast 2020-2025, by Region, in Volume

Table Price Factors List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950